This document discusses nanoparticles, including their definition as submicron colloidal structures composed of polymers that are 10-1000nm in size. Nanoparticles can be nanospheres or nanocapsules and are useful for site-specific drug delivery. Some key advantages are achieving maximum drug effects with minimal side effects through active and passive targeting. The document outlines various polymer types used in nanoparticle production and evaluation methods like particle size, surface charge, drug loading efficiency and in vitro drug release.